Reuters logo
Hikma says considering strategic options for injectables business
March 1, 2013 / 10:36 AM / in 5 years

Hikma says considering strategic options for injectables business

March 1 (Reuters) - Hikma Pharmaceuticals Plc said it reviewing options for its injectables business.

“We have received a number of unsolicited expressions of interest in our injectables business and will consider the best option for shareholders,” Chief Executive Said Darwazah said in a statement.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below